Clinical trials
Adverse Event clinical trials
Below are recruiting adverse event clinical trials, each written for real people, not researchers. We’re tracking 191 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05662293Recruiting
Study of heart muscle weakness caused by abnormal heart rhythms
This study looks at a condition where an abnormal heart rhythm can weaken the heart muscle (arrhythmia-induced cardiomyopathy). You may be asked questions, have heart tests reviewed, and help researchers better describe who is affected and how it develops.
BaselAges 18 years+ - NCT05717712RecruitingPhase 1
Study virus treatment for newly diagnosed DIPG in children
This Phase 1 trial tests a type of cancer-fighting virus given directly into the tumor for children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). The goal is to see if it can be delivered safely and to learn how the body responds to it.
Beijing, Beijing MunicipalityAges 1–18 - NCT05717699RecruitingPhase 1
Trial of a virus treatment for DIPG in children
This Phase 1 trial tests a lab-made cancer virus (Ad-TD-nsIL12) in children with DIPG whose tumor keeps growing after standard treatment. It mainly focuses on safety and how the treatment works, and it may help shrink or control the tumor by stimulating the immune system.
Beijing, Beijing MunicipalityAges 1–18 - NCT06114615Recruiting
Remote monitoring after heart treatment to prevent future events
This trial tests whether digital tools can help monitor patients after a stent procedure to lower the chance of another heart problem. It aims to make follow-up care easier and more effective.
Sacramento, CaliforniaAges Any age - NCT06537583Recruiting
Ear stimulation after a STEMI heart attack
This study tests whether gentle electrical stimulation near your ear (tragus) can help stabilize your heart's rhythm and reduce inflammation after a STEMI heart attack. It may help lower the risk of future heart problems.
Semarang, Central of JavaAges 18–70 - NCT06586424Recruiting
Can Anion Gap Predict Heart Risks After a Heart Attack?
This study checks if a simple blood test measure (anion gap) can help predict serious heart problems in people who have had a major heart attack (STEMI) and received emergency angioplasty. It may help doctors better understand your risk and guide future care.
Semarang, Central of JavaAges 18–70 - NCT06607445Recruiting
Testing a personalized medicine program in Extremadura
This study looks at a program called MedeA that uses your genes to help choose the right medicines for you. If you live in Extremadura and are starting or already on treatment, you may be able to join.
BadajozAges Any age - NCT06656988RecruitingPhase 3
Saving kidney function during leg artery treatment with carbon dioxide
This trial tests if using carbon dioxide gas instead of standard dye during a leg artery procedure can protect the kidneys. It is for people with blocked leg arteries who also have reduced kidney function.
InnsbruckAges 18 years+ - NCT06692504Recruiting
Blood Thinner Side Effects in the Emergency Room
This study looks at side effects of blood thinners (anticoagulants) in patients who visited the emergency department. It helps doctors understand how to better manage these medications.
BesançonAges 18 years+ - NCT06772961Recruiting
Electrical stimulation on acupoints to reduce breathing problems after surgery
This trial tests whether mild electrical stimulation at specific acupoints (on the arm and hand) before and after surgery can lower the chance of breathing complications when you wake up from general anesthesia.
Nanjing, JiangsuAges 18–100 - NCT06843005Recruiting
Heart CT scan study for plaque changes in mild coronary disease
This study uses repeat CT scans of the heart to see how plaque buildup changes over time in people with mild, non-blocking coronary artery disease. It may help doctors decide on better treatments to prevent future heart problems.
Nanjing, JiangsuAges 18–80 - NCT06885619Recruiting
Predicting heart outcomes after a first heart attack with blood tests
This study looks at blood tests and heart function after a first heart attack (STEMI) treated with emergency stenting. Researchers want to see if certain molecules in the blood can predict future heart problems.
Beijing, Beijing MunicipalityAges 18–80 - NCT06979284Recruiting
Ultrasound inside artery for severe leg blockages
This trial tests whether using a special ultrasound probe inside the artery (called intravascular ultrasound) helps guide treatment for people with severe leg artery blockages that cause pain, wounds, or gangrene. The goal is to see if it improves blood flow and saves the leg.
HamiltonAges 18 years+ - NCT07020858Recruiting
FAPI imaging for heart attack risk in blocked arteries
This trial tests whether a special scan called FAPI-PET can predict heart problems in people with a chronic total occlusion (a completely blocked heart artery for at least 3 months). If you have this type of blockage and are planning to have a procedure to open it, this study may help guide your care.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07063147Recruiting
Heart ultrasound for stable chest pain management
This study uses a heart ultrasound (TTE) to help doctors better manage stable chest pain. If you have chest pain that may be from a blocked artery but haven't had a heart attack or heart procedures before, this trial could help improve your care.
TianjinAges 18 years+ - NCT07216846Recruiting
Preventing medication harm in older adults after a fall
This trial tests a program for older adults (65+) who have had a fall at ground level. It aims to reduce harm from medications by using special care in the emergency department.
Delray Beach, FloridaAges 65–110 - NCT07164833RecruitingPhase 2
Testing a drug to prevent kidney injury after heart surgery
This study tests a new medicine, BX-001N, to see if it can prevent kidney damage during and after heart surgery for aortic disease. It is for people with moderate kidney problems who are having planned surgery that stops the heart briefly.
DaeguAges 19–90 - NCT07374263Recruiting
Do heart rhythm drugs pose risks in hospital?
This study looks at whether certain medications that can affect heart rhythm (QT-prolonging drugs) are linked to serious heart problems in adults who were hospitalized. It includes patients admitted to St. Joseph's Healthcare Hamilton or other GEMINI hospitals between 2017 and 2025.
Hamilton, OntarioAges 18 years+ - NCT02738047Recruiting
PGx test to reduce medication side effects and repeat hospital visits
This trial checks whether using a genetic (DNA) medication test—done within the last 120 days—can help reduce bad medication reactions and prevent readmissions to the hospital. It may help people whose medications have caused side effects or did not work well.
York, PennsylvaniaAges 25 years+ - NCT07672249Recruiting
Study on iliac stenting to prevent major leg events
This study looks at people with narrowed or blocked arteries in the pelvis (iliac arteries) who receive a stent to improve blood flow. It aims to understand which factors might predict future serious problems in the legs, like worsening pain or amputation.
Milan, MiAges 18 years+ - NCT06909565RecruitingPhase 4
Inclisiran to prevent heart and leg events after artery procedure
This study tests whether a twice-yearly injection called inclisiran can prevent heart attacks, strokes, or leg complications in people who recently had a procedure to open a blocked artery. You may be eligible if you had a heart or leg artery procedure within the last two weeks.
Alexander City, AlabamaAges 18 years+ - NCT06291597Recruiting
Vaping study: effects on lungs and heart
This study is looking at how daily vaping affects your lungs and heart over time. If you vape every day, researchers want to monitor your health to spot any early warning signs.
QuébecAges 18 years+ - NCT07039149Recruiting
Dual antiplatelet therapy for acute coronary syndrome
This trial tests giving two blood-thinning medicines early to people who have had a heart attack or unstable chest pain. Researchers want to see if this approach reduces future heart problems.
AmmanAges 18 years+
Hear when a new Adverse Event trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adverse event?
- Yes. Clin2 currently lists 191 recruiting adverse event studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adverse event trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adverse event trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.